Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Clinical trial NCT06034860 · TERMINATED

Trial details

NCT number: NCT06034860
Sponsor: Molecular Templates, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Hepatocellular Carcinoma Melanoma Renal Cell Carcinoma Microsatellite Instability High Mismatch Repair Deficiency Mesothelioma Esophageal Squamous Cell Carcinoma Squamous Cell Carcinoma of Head and Neck Urothelial Carcinoma Cervical Cancer

Start date: 2023-11-01
Primary completion: 2024-10-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.